Phase 2/3 Study of Effect of AT1RB Versus ACE Inhibitor in Addition to XO Inhibitor on Progression of LV Remodeling and Dysfunction in Diabetic Patients With Acute MI

Trial Profile

Phase 2/3 Study of Effect of AT1RB Versus ACE Inhibitor in Addition to XO Inhibitor on Progression of LV Remodeling and Dysfunction in Diabetic Patients With Acute MI

Completed
Phase of Trial: Phase II/III

Latest Information Update: 05 Jun 2015

At a glance

  • Drugs Candesartan cilexetil (Primary) ; Allopurinol; Ramipril
  • Indications Hypertension; Left ventricular dysfunction
  • Focus Pharmacodynamics
  • Acronyms P3
  • Most Recent Events

    • 01 Dec 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
    • 01 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top